Total Payments
$5,430
2024 Payments
$925.60
Companies
35
Transactions
248
Medicare Patients
24,241
Medicare Billing
$2.2M
Payment Breakdown by Category
Food & Beverage$5,232 (96.3%)
Consulting$198.31 (3.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,232 | 247 | 96.3% |
| Consulting Fee | $198.31 | 1 | 3.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| MERZ NORTH AMERICA, INC. | $791.37 | 14 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $597.80 | 32 | $0 (2024) |
| Galderma Laboratories, L.P. | $504.78 | 49 | $0 (2024) |
| LEO Pharma Inc. | $477.21 | 19 | $0 (2021) |
| REVANCE THERAPEUTICS, INC. | $426.97 | 9 | $0 (2024) |
| DUSA Pharmaceuticals, Inc. | $362.48 | 10 | $0 (2019) |
| PFIZER INC. | $271.64 | 18 | $0 (2023) |
| VYNE Pharmaceuticals Inc. | $224.72 | 8 | $0 (2021) |
| ABBVIE INC. | $197.35 | 9 | $0 (2024) |
| GENZYME CORPORATION | $179.87 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $925.60 | 30 | REVANCE THERAPEUTICS, INC. ($426.97) |
| 2023 | $692.48 | 33 | Sun Pharmaceutical Industries Inc. ($164.93) |
| 2022 | $651.15 | 22 | Merz North America, Inc. ($216.09) |
| 2021 | $524.88 | 24 | VYNE Pharmaceuticals Inc. ($165.03) |
| 2020 | $314.51 | 17 | VYNE Pharmaceuticals Inc. ($59.69) |
| 2019 | $758.77 | 34 | Merz North America, Inc. ($209.75) |
| 2018 | $787.79 | 45 | Merz North America, Inc. ($222.11) |
| 2017 | $775.30 | 43 | DUSA Pharmaceuticals, Inc. ($233.35) |
All Payment Transactions
248 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: DERMATOLOGY | ||||||
| 12/06/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $31.41 | General |
| Category: Immunology | ||||||
| 12/03/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $60.00 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/22/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $32.36 | General |
| Category: DERMATOLOGY | ||||||
| 11/11/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $36.32 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/05/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $28.38 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: DERMATOLOGY | ||||||
| 10/23/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Dermatology | ||||||
| 10/22/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $86.13 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 10/21/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $26.71 | General |
| Category: Dermatology | ||||||
| 09/30/2024 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: Dermatology | ||||||
| 08/27/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $24.89 | General |
| 08/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Immunology | ||||||
| 08/19/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $87.50 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 08/14/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $27.61 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 07/24/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $28.34 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 06/13/2024 | Galderma Laboratories, L.P. | DYSPORT (Biological) | Food and Beverage | In-kind items and services | $19.53 | General |
| 05/08/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $29.97 | General |
| 05/06/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 05/03/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: ACNE | ||||||
| 04/22/2024 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Dermatology | ||||||
| 04/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $32.73 | General |
| Category: FACIAL AESTHETICS | ||||||
| 04/03/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Dermatology | ||||||
| 03/06/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $22.77 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 6,325 | 9,980 | $1.8M | $589,588 |
| 2022 | 24 | 6,243 | 9,845 | $1.8M | $572,462 |
| 2021 | 26 | 6,391 | 10,331 | $1.8M | $594,374 |
| 2020 | 23 | 5,282 | 8,454 | $1.4M | $444,797 |
Total Patients
24,241
Total Services
38,610
Medicare Billing
$2.2M
Procedure Codes
96
All Medicare Procedures & Services
96 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 919 | 1,139 | $312,455 | $102,833 | 32.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,010 | 1,447 | $281,508 | $93,306 | 33.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 987 | 1,295 | $282,777 | $89,771 | 31.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 529 | 630 | $152,750 | $53,385 | 34.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 886 | 1,316 | $190,340 | $49,003 | 25.7% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 219 | 279 | $108,171 | $35,477 | 32.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 349 | 649 | $70,507 | $27,054 | 38.4% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 55 | 75 | $58,705 | $22,923 | 39.0% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 56 | 67 | $57,942 | $21,427 | 37.0% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 46 | 48 | $44,474 | $17,054 | 38.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 197 | 197 | $48,521 | $14,710 | 30.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 583 | 2,310 | $32,340 | $12,214 | 37.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 80 | 80 | $28,986 | $9,701 | 33.5% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 74 | 83 | $26,442 | $8,334 | 31.5% |
| 96573 | Application of light by qualified health care professional to destroy precancer skin growth | Office | 2023 | 42 | 47 | $22,523 | $7,586 | 33.7% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 63 | 73 | $38,831 | $7,477 | 19.3% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 38 | 39 | $23,916 | $4,583 | 19.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 85 | 92 | $11,188 | $3,871 | 34.6% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 14 | 14 | $8,216 | $2,854 | 34.7% |
| 69100 | Biopsy of ear | Office | 2023 | 49 | 52 | $10,952 | $2,771 | 25.3% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 16 | 18 | $7,380 | $2,763 | 37.4% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 14 | 15 | $1,872 | $477.66 | 25.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 14 | 15 | $45.00 | $11.85 | 26.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 907 | 1,123 | $316,686 | $99,121 | 31.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 963 | 1,339 | $266,263 | $87,942 | 33.0% |
About Dr. Kimberly Davidson, M.D
Dr. Kimberly Davidson, M.D is a Procedural Dermatology healthcare provider based in Naples, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770559510.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kimberly Davidson, M.D has received a total of $5,430 in payments from pharmaceutical and medical device companies, with $925.60 received in 2024. These payments were reported across 248 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($5,232).
As a Medicare-enrolled provider, Davidson has provided services to 24,241 Medicare beneficiaries, totaling 38,610 services with total Medicare billing of $2.2M. Data is available for 4 years (2020–2023), covering 96 distinct procedure/service records.
Ad
Practice Information
- Specialty Procedural Dermatology
- Location Naples, FL
- Active Since 02/23/2006
- Last Updated 03/07/2023
- Taxonomy Code 207NS0135X
- Entity Type Individual
- NPI Number 1770559510
Products in Payments
- ENSTILAR (Drug) $477.21
- DAXXIFY (Drug) $426.97
- EUCRISA (Drug) $271.64
- Levulan (Drug) $233.35
- Winlevi (Drug) $231.80
- AMZEEQ (Drug) $217.30
- BLU-U (Medical Supply) $184.74
- DUPIXENT (Biological) $179.87
- VTAMA (Drug) $168.76
- OPZELURA (Drug) $132.41
- DORYX (Drug) $125.11
- XEOMIN (Biological) $120.79
- Absorica LD (Drug) $107.44
- ORACEA (Drug) $95.70
- LEVULAN KERASTICK (Drug) $74.97
- NAFTIN (Drug) $65.68
- Cloderm Cream (Drug) $63.64
- QBREXZA (Drug) $59.66
- BOTOX (Biological) $57.30
- Ameluz (Drug) $55.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.